Showing 2,387 news articles about HIV treatment

Filters Content type: Editors' picks Topic: HIV treatment

Treatment is recommended for all people living with HIV. It involves taking a combination of antiretroviral drugs. This stops the virus from replicating and allows the immune system to strengthen and fight infections.

Injectable & long-acting HIV treatment

Women Find Long-Acting Injectable ART 'Emotionally Freeing and Empowering'

Editor's pick
Contagion Live
7 October 2019
Treatment simplification strategies

Some issues to consider with Dovato (dolutegravir + 3TC)

Editor's pick
CATIE
3 October 2019
PrEP science

Evaluating Microarray Patches for Long-Acting PrEP and Contraceptives

Editor's pick
Contagion Live
3 October 2019
New & experimental HIV treatments

European Commission Approves Trogarzo

Editor's pick
Global Newswire
27 September 2019
Side effects

Unsure whether I'll join Gilead lawsuit

Editor's pick
Bay Area Reporter
27 September 2019
Injectable & long-acting HIV treatment

HIV implant targets disease for up to a year

Editor's pick
The Engineer
26 September 2019
PrEP science

Long-acting injectable multi-drug implant shows promise for HIV prevention and treatment

Editor's pick
EurekAlert
23 September 2019
Changing treatment

FDA Expands Indications for Pifeltro and Delstrigo for HIV

Editor's pick
Medscape (requires free registration)
23 September 2019
Treatment outcomes & life expectancy

What’s causing deaths among HIV-positive people in San Francisco?

Editor's pick
CATIE
23 September 2019
Cardiovascular disease

Switching Back to Older Tenofovir Improves Lipid Levels

Editor's pick
POZ
12 September 2019
Contraception

AVAC’s Take on Updated WHO Guidance on Hormonal Contraception and HIV Risk

Editor's pick
AVAC
29 August 2019
Contraception

Guidance statement - Recommendations on contraceptive methods used by women at high risk of HIV

Editor's pick
World Health Organization
29 August 2019
Treatment outcomes & life expectancy

HIV-positive New Yorkers are living longer but still dying from underlying infection, not just from old age

Editor's pick
EurekAlert
29 August 2019
Side effects

Those Truvada Lawsuit Ads You See Everywhere May Hinder Public Health Efforts

Editor's pick
TheBody
28 August 2019
Changing treatment

‘Alarming’ rates of second-line HIV treatment failure in sub-Saharan Africa

Editor's pick
Avert
22 August 2019
HIV treatment for children & young people

Dolutegravir for younger children: results from the ODYSSEY trial

Editor's pick
HIV i-Base
22 August 2019
New & experimental HIV treatments

ViiV Healthcare reports positive phase III study results of investigational, long-acting, injectable HIV-treatment regimen administered every two months

Editor's pick
GSK press release
22 August 2019
Bad science & bogus treatments

Catfished by a Fake AIDS Conference!

Editor's pick
TheBody
20 August 2019
Kidney problems

Change in Kidney Function After TDF-to-TAF Switch: Who Benefits Most?

Editor's pick
NATAP
10 August 2019
Injectable & long-acting HIV treatment

DURECT and Gilead Enter into License Agreement for Long-Acting Injectable HIV Investigational Product

Editor's pick
DURECT press release
6 August 2019
Resistance

Alarming surge in drug-resistant HIV uncovered

Editor's pick
Nature
3 August 2019
Changing treatment

High efficacy from switching to bictegravir/F/TAF in virally suppressed participants – including analyses by baseline drug resistance

Editor's pick
i-Base
2 August 2019
People with limited treatment options

Clinical and Economic Effects of Ibalizumab for Multidrug-Resistant HIV

Editor's pick
Infectious Disease Advisor
2 August 2019
Injectable & long-acting HIV treatment

ViiV Healthcare submits regulatory application to EMA for the first monthly, injectable treatment for HIV

Editor's pick
ViiV press release
30 July 2019